Concepedia

Ronald C. DeConti

RC

Statistics

Publications

68

Citations

9.1K

H-Index

45

Active since

1966

Affiliations

Moffitt Cancer Center(Current)

University of South Florida

Yale University

University of California, San Francisco

Dana-Farber Cancer Institute

Ronald C. DeConti is an author at Moffitt Cancer Center specializing in oncology, medicine, and chemotherapy.

Publications per year

1966–2017

68

Publications

68

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

Adil Daud, Ronald C. DeConti, Stephanie Andrews et al. · Journal of Clinical Oncology · 2008 · 688 citations

, , +16

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Agop Y. Bedikian, Michael Millward, Hubert Pehamberger et al. · Journal of Clinical Oncology · 2006 · 597 citations

, , +14

Intraoperative Radiolymphoscintigraphy Improves Sentinel Lymph Node Identification for Patients with Melanoma

John J. Albertini, C. Wayne Cruse, David P. Rapaport et al. · Annals of Surgery · 1996 · 521 citations

, , +17

Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group

Michael K. Gibson, Yi Li, Barbara A. Murphy et al. · Journal of Clinical Oncology · 2005 · 494 citations

, , +14

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma

Katsutaro Shimaoka, David Schoenfeld, William D. DeWys et al. · Cancer · 1985 · 464 citations · Full text

, , +17

1–5 of 68